Evidence for a cannabinoid receptor in immunomodulation by cannabinoid compounds.
Kaminski
N E
NE
Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002186:Cannabinoids / Q000494:pharmacology*; D002478:Cells, Cultured; D005576:Colforsin / Q000494:pharmacology; D003511:Cyclohexanols / Q000378:metabolism / Q000494:pharmacology; D013759:Dronabinol / Q000031:analogs & derivatives / Q000494:pharmacology; D005260:Female; D007109:Immunity / Q000187:drug effects*; D007075:Immunoglobulin M / Q000096:biosynthesis; D051379:Mice; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000502:physiology*; D013154:Spleen / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D013237:Stereoisomerism
D002186:Cannabinoids; D003511:Cyclohexanols; D007075:Immunoglobulin M; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug; D005576:Colforsin; D013759:Dronabinol; C054649:3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol; D000262:Adenylyl Cyclases; C062018:HU 211